FDA says tirzepatide shortage is over after taking a second look

The FDA said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly’s diabetes and weight loss drugs Mounjaro and Zepbound — is over.

Topics

FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage

The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
CNBC - 11h
FDA keeps Mounjaro off shortage list after reevaluation

The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a reevaluation of its decision to remove it from federal drug shortage list amid ...
The Hill - 14h
FDA warns companies over unapproved weight loss drug sales

The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides, Swisschems, ...
The Hill - 1d
Cooper Flagg Tracker: Star freshman takes over in second half of Blue Devils' easy win vs. George Mason

Flagg scored 17 of his 24 points in the second half as No. 5 Duke defeated George Mason on Tuesday
CBS Sports - 1d
Iran imposes city shutdowns over smog and energy shortages

President Masoud Pezeshkian calls on population to conserve enough gas to last freezing winter
Financial Times - 3d
LOOK: Mark Gastineau confronts Brett Favre for 'taking a dive' that gave Michael Strahan sack record over him

Gastineau is still hot two decades after the fact
CBS Sports - Dec. 10
Syrians return home after HTS rebels take over, Assad flees

Syrians are reacting after President Bashar al-Assad's regime was toppled by rebel forces affiliated with the militant group Hayat Tahrir al-Shams (HTS). CBS News' Courtney Kealy has more.
CBS News - Dec. 9
Bill Belichick open to taking UNC job after second meeting with school, doesn't want to be shut out of job

The six-time Super Bowl champion doesn't want to be shut out again this coaching cycle
CBS Sports - Dec. 8
Supreme Court divided over FDA block on kid-friendly flavored vapes

With e-cigarette sales booming, the Supreme Court heard arguments over whether the FDA unlawfully blocked approval of more than a million new flavored nicotine products.
ABC News - Dec. 2

FDA says tirzepatide shortage is over after taking a second look

Topics

Related

FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage

FDA keeps Mounjaro off shortage list after reevaluation

FDA warns companies over unapproved weight loss drug sales

Cooper Flagg Tracker: Star freshman takes over in second half of Blue Devils' easy win vs. George Mason

Iran imposes city shutdowns over smog and energy shortages

LOOK: Mark Gastineau confronts Brett Favre for 'taking a dive' that gave Michael Strahan sack record over him

Syrians return home after HTS rebels take over, Assad flees

Bill Belichick open to taking UNC job after second meeting with school, doesn't want to be shut out of job

Supreme Court divided over FDA block on kid-friendly flavored vapes

More from NBC News

Congress scrambles to save spending plan to avoid government shutdown

Suspect in CEO killing extradited from Pennsylvania to New York

FDA ruling limits which foods can be labeled 'healthy' on packaging

U.S. life expectancy rose significantly last year, hitting highest level since pandemic

A young woman's body was chopped up for science — as her mother desperately fought to bring her home